News

Nanodigmbio @ AACR2023

View: 4271 / Time: 2023-04-27

The 2023 AACR Annual Meeting, a six-day event hosted by the American Association for Cancer Research (AACR), successfully concluded on April 19th, 2023, in Orlando, Florida, USA. 


Nanodigmbio, a specialized supplier of self-developed high-quality targeted sequencing total solutions, was proud to participate in this prestigious gathering.


The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world.


640 (1)


Nanaodigmbio made its first appearance at AACR with its NGS integrated solution and innovative μCaler hybrid capture technology, marking the beginning of its journey to expand into overseas markets.


The Nanodigmbio booth drew many visitors who stopped to negotiate. The senior technical team of Nanodigmbio explained the details of μCaler hybrid capture technology and NGS target sequencing solution to visitors with enthusiasm and patience. They also helped more experts and customers in the field understand the Nanodigmbio brand and the company's products. Many of them expressed a keen interest in Nanodigmbio and its innovative technologies and product applications.


111111111111


Nanodigmbio has successfully completed its first overseas stop at AACR in 2023. As a technology-based enterprise, we are committed to showcasing our excellent technology and high-quality products in other international markets in our annual exhibition planning. Our goal is to share Chinese technology with people around the world and better serve the needs of the international market. We are excited to continue exploring opportunities in the field of molecular diagnostics and making new breakthroughs in the future. 


Thank you for joining us at AACR, and we look forward to meeting you at our next exhibition!